Calcium channel blockers as tocolytics

Seminars in Perinatology

Volumn 25, Issue 5, 2001, Pages 264-271

  Economy, Katherine E ^a,b   Abuhamad, Alfred Z ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; UTERUS SPASMOLYTIC AGENT;

BREAST FEEDING; CALCIUM TRANSPORT; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; FETUS HYPOXIA; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; HYPOTENSION; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE TONE; TOCOLYSIS;

EID: 0034752209     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2001.27165     Document Type: Article

References (67)

1. Calcium-antagonist drugs
2. Newer possibilities of tocolytic treatment in obstetrics
3. Treatment of premature labor with the calcium antagonist nifedipine
4. The mechanism of action of calcium antagonists relative to their clinical applications
5. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells
6. Endothelin-imediated vasoconstriction: Specific blockade by verapamil
7. Noradrenaline contracts arteries by activating voltage-dependent calcium channels
8. T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells
9. Human fetal membranes release a Ca+ + channel inhibitor
10. Abnormality of calcium channel inhibitor released from fetal membranes in preterm labor
11. Pharmacokinetics of calcium antagonists under development
12. Pharmacokinetics and metabolism of nifedipine
13. Nifedipine and its indications in obstetrics and gynecology
14. Single dose of nifedipine in normotensive pregnancy: Nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms
15. Nifedipine pharmacokinetics during preterm labor tocolysis
16. Nifedipine and ritodrine in the management of preterm labor: A randomized multicenter trial
17. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety
18. Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe
19. Pregnancy outcome in women exposed to calcium channel blockers
20. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study
21. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers
22. Nifedipine transfer into human milk
23. Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe
24. Cardiovascular and uterine blood flow changes during nicardipine HCl tocolysis in the rabbit
25. The effects of nifedipine on pregnancy outcome and morphology of the placenta, uterus, and cervix during late pregnancy in the rat
26. Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor
27. The use of a calcium antagonist (nifedipine) to suppress preterm labour
28. Nifedipine versus ritodrine for suppressing preterm labor
29. A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal, and neonatal outcome
30. Comparison of nifedipine and ritodrine for the treatment of preterm labor
31. A randomized comparison of nifedipine and ritodrine for suppression of preterm labor
32. Nifedipine versus ritodrine for suppression of preterm labour
33. Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis
34. A prospective randomized trial of nifedipine vs. ritrodrine in threatened preterm labor
35. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: A randomized study
36. Prevention of preterm delivery: Nifedipine or magnesium sulfate
37. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor
38. Neonatal effects of nifedipine and ritodrine for preterm labor
39. Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine
40. The effects of aminophylline and nifedipine on contractility of isolated pregnant human myometrium
41. Inhibition of prostaglandin-induced uterine activity by nifedipine
42. Inhibition of myometrial activity by calcium antagonists
43. Effects of nifedipine on oxytocin- and prostaglandin F2 alpha-induced activity in the postpartum uterus
44. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: Fetal plasma concentrations and cardiorespiratory changes
45. Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep
46. The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat
47. Uterine and fetal flow velocity waveforms in hypertensive pregnancy: The effect of a single dose of nifedipine
48. Nicardipine treatment of hypertension during pregnancy
49. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis
50. Management of preterm labour. Nifedipine in management of preterm labour is safe
51. A randomized study of the treatment of threatened premature labor. Nifedipine versus ritodrine
52. Diltiazem for maintenance tocolysis of preterm labor: Comparison to nifedipine in a randomized trial
53. Maintenance oral nifedipine for preterm labor: A randomized clinical trial
54. Nifedipine versus ritodrine for suppression of preterm labor; A meta-analysis
55. Nifedipine versus ritodrine for suppression of preterm labor; A meta-analysis
56. Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist
57. The risk of myocardial infarction associated with antihypertensive drug therapies
58. Corrections to the nifedipine meta-analysis
59. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
60. Analysis of the risks associated with calcium channel blockade: Implications for the obstetrician-gynecologis
61. Myocardial infarction during nifedipine therapy for preterm labor
62. Calcium-channel blockers and risk of cancer
63. Neuromuscular blockade with magnesium sulfate and nifedipine
64. The combination of magnesium sulphate and nifedipine: A cause of neuromuscular blockade
65. Nifedipine enhances the cardiac toxicity of magnesium sulfate in the isolated perfused Sprague-Dawley rat heart
66. Magnesium plus nifedipine: Potentiation of hypotensive effect in preeclampsia?